Behzad Aghazadeh

Sio Capital Management LLC (Sio Capital) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Michael Castor in 2006. Sio Capital provides discretionary investment advisory services to domestic and foreign private investment vehicles that are exempt from registration under the Investment Company Act of 1940 and separately managed accounts for institutions and large businesses.

venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California.

AllianceBernstein LP (AB) is a SEC-registered investment advisor and mutual fund manager headquartered in Nashville, Tennessee. Founded in 2000, the firm is owned by Equitable Financial Life Insurance Co., ultimately held by Equitable Holdings, Inc. (NYSE: EQH). AB provides investment advice to investment companies, pension and profit-sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations and other business entities.

Strategy& engages in the provision of global management consulting services. It serves industries including aerospace and defense; health; oil and gas; technology; automotive; entertainment and media; power and utilities; telecommunications; and transportation. The company was founded in 1914 and is headquartered in New York, NY.

Avoro Capital Advisor LLC (AVCAP) is a SEC-registered investment advisor and hedge fund management subsidiary of Avoro Capital LP. The firm was founded by Corey Goodman in 2009 as venBio Select Advisor LLC. In 2019, a strategic transaction was closed whereby venBio Select Advisor LP entered into an agreement to sell its wholly-owned subsidiary, venBio Select Advisor LLC, the investment manager of the venBio Select Funds, to a newly-formed holding company, Avoro Capital LP. Headquartered in New York, AVCAP provides investment advice and management to privately placed investment funds and separately managed account for high net-worth individuals.

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA.